Stay updated on EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added the Squamous cell carcinoma of the head and neck term and a Resources entry linking to the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-04-02T00:31:45.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-03-18T18:02:31.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T18:00:39.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed. The earlier government funding/operating-status notice has been removed.
    Difference
    0.4%
    Check dated 2026-02-11T10:57:21.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Site-wide notice added regarding a funding lapse that may affect data currency and operations, and the page revision updated to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T06:25:27.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    New study-record metadata appears: Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and a site revision label Revision: v3.4.0. The previous items Results First Posted (Estimated), Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4 were removed.
    Difference
    0.3%
    Check dated 2026-01-28T04:32:35.000Z thumbnail image

Stay in the know with updates to EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page.